DYN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.77%

Insider Buying (Last 12 Months): $29,999,987.50

Insider Selling (Last 12 Months): $53,603,933.08

Dyne Therapeutics Insider Trading History Chart

Dyne Therapeutics Share Price & Price History

^$24.73

▲ +1.04 (4.39%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Dyne Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2024	Joshua T Brumm	CEO	Sell	66,387	$25.67	$1,704,154.29	537,998
3/11/2024	Richard William Scalzo	SVP	Sell	2,672	$25.28	$67,548.16	119,283
3/11/2024	Susanna High	COO	Sell	2,292	$25.70	$58,904.40	156,800
3/11/2024	Wildon Farwell	Insider	Sell	1,585	$25.70	$40,734.50	151,590
3/7/2024	Joshua T Brumm	CEO	Sell	9,086	$25.85	$234,873.10	554,385
3/7/2024	Oxana Beskrovnaya	Insider	Sell	2,373	$25.85	$61,342.05	154,433
3/7/2024	Richard William Scalzo	SVP	Sell	2,273	$25.85	$58,757.05	121,955
3/7/2024	Susanna High	COO	Sell	1,591	$25.85	$41,127.35	186,291
2/29/2024	Jonathan Mcneill	Insider	Sell	4,268	$27.50	$117,370.00	143,618
2/29/2024	Joshua T Brumm	CEO	Sell	5,520	$27.50	$151,800.00	563,471
2/29/2024	Richard William Scalzo	SVP	Sell	3,429	$27.50	$94,297.50	124,228
2/28/2024	Jason P Rhodes	Director	Sell	190,920	$24.84	$4,742,452.80	864,487
2/28/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	154,674	$24.84	$3,842,102.16	5,698,091
2/26/2024	Jason P Rhodes	Director	Sell	248,219	$23.72	$5,887,754.68	903,527
2/26/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	201,095	$23.72	$4,769,973.40	6,151,467
2/23/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	159,542	$22.70	$3,621,603.40	6,352,562
2/22/2024	Jason P Rhodes	Director	Sell	119,360	$22.66	$2,704,697.60	6,512,104
2/21/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	184,501	$22.57	$4,164,187.57	6,631,464
2/20/2024	Jason P Rhodes	Director	Sell	169,539	$22.72	$3,851,926.08	6,815,965
2/16/2024	Venture Fund Xi L.P. Atlas	Major Shareholder	Sell	162,707	$23.14	$3,765,039.98	6,985,504
2/15/2024	Jason P Rhodes	Director	Sell	177,906	$23.89	$4,250,174.34	7,148,211
2/12/2024	Wildon Farwell	Insider	Sell	5,493	$25.07	$137,709.51	163,503
1/26/2024	Richard William Scalzo	SVP	Sell	13,000	$24.34	$316,420.00	124,228
1/26/2024	Wildon Farwell	Insider	Sell	100	$25.00	$2,500.00	168,996
1/9/2024	Dirk Kersten	Director	Buy	1,714,285	$17.50	$29,999,987.50	6,416,793
1/4/2024	Joshua T Brumm	CEO	Sell	218,536	$18.51	$4,045,101.36	584,971
1/3/2024	Oxana Beskrovnaya	Insider	Sell	45,326	$18.98	$860,287.48	176,585
1/3/2024	Richard William Scalzo	SVP	Sell	13,000	$18.81	$244,530.00	124,228
12/14/2023	Richard William Scalzo	Insider	Sell	2,376	$12.02	$28,559.52	124,228
12/11/2023	Richard William Scalzo	Insider	Sell	1,380	$10.72	$14,793.60	126,604
12/11/2023	Susanna High	COO	Sell	1,616	$10.72	$17,323.52	187,882
12/6/2023	Richard William Scalzo	Insider	Sell	1,872	$12.01	$22,482.72	127,984
12/4/2023	Richard William Scalzo	Insider	Sell	681	$12.01	$8,178.81	129,856
11/2/2023	Susanna High	COO	Sell	9,939	$7.40	$73,548.60	94,605
9/18/2023	Richard William Scalzo	Insider	Sell	1,290	$9.41	$12,138.90	40,795
9/18/2023	Susanna High	COO	Sell	2,672	$9.41	$25,143.52	104,544
9/12/2023	Susanna High	COO	Sell	1,635	$10.41	$17,020.35	107,216
9/12/2023	Wildon Farwell	Insider	Sell	1,707	$10.41	$17,769.87	89,250
6/15/2023	Richard William Scalzo	Insider	Sell	10,000	$12.03	$120,300.00	43,482
6/13/2023	Susanna High	COO	Sell	1,625	$12.43	$20,198.75	108,851
6/12/2023	Joshua T Brumm	Insider	Sell	187,748	$12.61	$2,367,502.28	253,383
6/9/2023	Joshua T Brumm	Insider	Sell	76,582	$13.34	$1,021,603.88	269,771
3/14/2023	Richard William Scalzo	Insider	Sell	1,311	$13.33	$17,475.63	54,872
3/14/2023	Susanna High	COO	Sell	1,559	$13.33	$20,781.47	110,476
1/18/2023	Jonathan Mcneill	Insider	Sell	10,000	$14.03	$140,300.00	67,600
1/9/2023	Jonathan Mcneill	Insider	Sell	30,150	$11.57	$348,835.50	67,600
12/12/2022	Jason P Rhodes	Director	Buy	934,581	$10.70	$10,000,016.70	934,581
12/12/2022	Richard William Scalzo	Insider	Sell	312	$10.87	$3,391.44	56,183
12/12/2022	Susanna High	COO	Sell	751	$10.87	$8,163.37	112,035
10/10/2022	Joshua T Brumm	Insider	Sell	195,800	$12.46	$2,439,668.00	204,623
10/7/2022	Joshua T Brumm	Insider	Sell	14,200	$13.37	$189,854.00	204,623
3/11/2022	Richard William Scalzo	Insider	Sell	308	$8.73	$2,688.84
3/11/2022	Susanna High	COO	Sell	765	$8.73	$6,678.45
3/2/2022	Wildon Farwell	Insider	Sell	5,617	$8.56	$48,081.52
9/23/2021	Susanna High	COO	Sell	2,451	$17.22	$42,206.22
9/20/2021	Richard William Scalzo	Insider	Sell	367	$15.61	$5,728.87

Exposed: 10 CENT Crypto to Explode April 20th?

From True Market Insiders | Ad

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024

SEC Filings (Institutional Ownership Changes) for Dyne Therapeutics (NASDAQ:DYN)

96.68% of Dyne Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Dyne Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2024	Wetzel Investment Advisors Inc.	1,000	$28K	0.0%	N/A	0.001%
4/23/2024	Arcadia Investment Management Corp MI	31,325	$0.89M	0.2%	N/A	0.036%
4/22/2024	Vivo Capital LLC	1,635,136	$46.42M	3.6%	+58.0%	1.897%
4/22/2024	Raymond James & Associates	168,963	$4.80M	0.0%	+95.3%	0.196%
4/18/2024	Wasatch Advisors LP	417,794	$11.86M	0.1%	-75.2%	0.485%
4/18/2024	Allspring Global Investments Holdings LLC	1,210	$34K	0.0%	-47.8%	0.001%
4/12/2024	Vida Ventures Advisors LLC	407,499	$11.57M	6.4%	-80.4%	0.473%
3/7/2024	Fcpm Iii Services B.V.	6,131,079	$81.54M	24.2%	N/A	9.989%
3/5/2024	Wellington Management Group LLP	145,474	$1.94M	0.0%	+25.5%	0.237%
2/15/2024	Octagon Capital Advisors LP	792,945	$10.55M	1.7%	+14.4%	1.292%
2/15/2024	Frazier Life Sciences Management L.P.	1,184,840	$15.76M	0.8%	N/A	1.930%
2/14/2024	Commodore Capital LP	900,000	$11.97M	1.1%	N/A	1.466%
2/14/2024	Braidwell LP	755,811	$10.05M	0.4%	-58.5%	1.231%
2/14/2024	Wasatch Advisors LP	1,684,517	$22.40M	0.1%	-0.2%	2.744%
2/13/2024	Tower Research Capital LLC TRC	6,795	$90K	0.0%	-14.9%	0.011%
2/13/2024	Armistice Capital LLC	824,000	$10.96M	0.1%	-31.3%	1.342%
2/13/2024	Rafferty Asset Management LLC	164,041	$2.18M	0.0%	+17.7%	0.267%
2/12/2024	Redmond Asset Management LLC	12,500	$0.17M	0.1%	-5.4%	0.020%
2/9/2024	Franklin Resources Inc.	1,913,832	$25.45M	0.0%	+0.0%	3.118%
2/9/2024	Trexquant Investment LP	22,822	$0.30M	0.0%	N/A	0.037%
2/6/2024	Swiss National Bank	60,200	$0.80M	0.0%	-5.2%	0.098%
2/6/2024	New York Life Investment Management LLC	30,210	$0.40M	0.0%	-2.3%	0.049%
2/5/2024	Russell Investments Group Ltd.	100,496	$1.34M	0.0%	-31.7%	0.164%
2/1/2024	New York State Common Retirement Fund	18,592	$0.25M	0.0%	+13.7%	0.030%
2/1/2024	Jennison Associates LLC	202,871	$2.70M	0.0%	N/A	0.331%
1/31/2024	Federated Hermes Inc.	375,000	$4.99M	0.0%	N/A	0.611%
1/25/2024	Allspring Global Investments Holdings LLC	2,318	$31K	0.0%	-75.1%	0.004%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	22,921	$0.31M	0.0%	+5.5%	0.037%
1/24/2024	China Universal Asset Management Co. Ltd.	7,099	$94K	0.0%	+355.6%	0.012%
1/17/2024	Assenagon Asset Management S.A.	286,644	$3.81M	0.0%	-60.3%	0.467%
1/16/2024	Raymond James & Associates	86,497	$1.15M	0.0%	-2.0%	0.141%
1/12/2024	SG Americas Securities LLC	12,938	$0.17M	0.0%	N/A	0.021%
1/5/2024	Vida Ventures Advisors LLC	2,074,787	$27.60M	32.9%	-6.5%	3.380%
12/18/2023	Vanguard Group Inc.	2,364,314	$21.18M	0.0%	-1.0%	3.852%
12/6/2023	Citigroup Inc.	61,895	$0.56M	0.0%	+22.8%	0.101%
12/1/2023	Wellington Management Group LLP	115,935	$1.04M	0.0%	+4.9%	0.189%
11/21/2023	Walleye Capital LLC	280,276	$2.51M	0.0%	N/A	0.457%
11/15/2023	Acuta Capital Partners LLC	146,500	$1.31M	0.9%	+100.7%	0.239%
11/15/2023	Armistice Capital LLC	1,200,000	$10.75M	0.2%	+31.6%	1.955%
11/14/2023	Braidwell LP	1,821,972	$16.33M	0.5%	+32.2%	2.968%
11/14/2023	Corton Capital Inc.	19,926	$0.18M	0.1%	+51.7%	0.032%
11/14/2023	Profund Advisors LLC	23,793	$0.21M	0.0%	+9.8%	0.039%
11/13/2023	Algert Global LLC	158,713	$1.42M	0.1%	-33.6%	0.259%
11/13/2023	FMR LLC	846,360	$7.58M	0.0%	-5.9%	1.379%
11/13/2023	Rafferty Asset Management LLC	139,409	$1.25M	0.0%	+18.9%	0.227%
11/9/2023	Citigroup Inc.	61,895	$0.56M	0.0%	+22.8%	0.101%
11/8/2023	Vivo Capital LLC	1,035,136	$9.28M	1.1%	+79.2%	1.686%
11/8/2023	New York Life Investment Management LLC	30,906	$0.28M	0.0%	-13.6%	0.050%
11/7/2023	Barclays PLC	99,574	$0.89M	0.0%	+21.5%	0.162%
11/6/2023	Assenagon Asset Management S.A.	721,474	$6.46M	0.0%	+24.5%	1.175%
11/2/2023	Principal Financial Group Inc.	15,229	$0.14M	0.0%	+10.7%	0.025%
11/1/2023	Simplex Trading LLC	36,032	$0.32M	0.0%	N/A	0.059%
10/27/2023	Allspring Global Investments Holdings LLC	9,310	$83K	0.0%	+95.7%	0.015%
10/27/2023	TD Asset Management Inc	23,000	$0.21M	0.0%	N/A	0.038%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	8,379	$75K	0.0%	+58.5%	0.014%
10/24/2023	Bank of New York Mellon Corp	157,443	$1.41M	0.0%	+4.8%	0.258%
10/24/2023	Raymond James & Associates	88,238	$0.79M	0.0%	+22.6%	0.145%
9/21/2023	Barclays PLC	81,971	$0.92M	0.0%	+155.5%	0.134%
8/15/2023	Sphera Funds Management LTD.	119,918	$1.35M	0.2%	-45.3%	0.197%
8/14/2023	ArrowMark Colorado Holdings LLC	382,416	$4.30M	0.0%	+39.0%	0.627%
8/14/2023	Deep Track Capital LP	2,499,912	$28.12M	1.3%	+7.1%	4.097%
8/14/2023	Polar Capital Holdings Plc	500,000	$5.63M	0.0%	N/A	0.819%
8/11/2023	VR Adviser LLC	2,173,913	$24.46M	3.9%	N/A	3.563%
8/11/2023	B. Metzler seel. Sohn & Co. AG	37,946	$0.43M	0.0%	+100.0%	0.062%
8/11/2023	Franklin Resources Inc.	1,913,479	$21.53M	0.0%	+1.1%	3.136%
8/11/2023	Trexquant Investment LP	27,380	$0.31M	0.0%	-35.5%	0.045%
8/11/2023	Artal Group S.A.	815,085	$9.17M	0.3%	+53.0%	1.336%
8/11/2023	ExodusPoint Capital Management LP	34,484	$0.39M	0.0%	+32.6%	0.057%
8/10/2023	Profund Advisors LLC	21,662	$0.24M	0.0%	N/A	0.035%
8/10/2023	Russell Investments Group Ltd.	111,304	$1.25M	0.0%	+371.1%	0.182%
8/8/2023	Candriam S.C.A.	723,624	$8.14M	0.1%	+14.2%	1.186%
8/8/2023	Wasatch Advisors LP	2,259,535	$25.42M	0.2%	-22.8%	3.703%
8/8/2023	International Biotechnology Trust PLC	300,751	$3.38M	1.0%	-30.7%	0.493%
8/7/2023	Principal Financial Group Inc.	13,753	$0.16M	0.0%	+18.4%	0.023%
8/7/2023	New York Life Investment Management LLC	35,776	$0.40M	0.0%	-15.6%	0.059%
8/4/2023	American International Group Inc.	20,458	$0.23M	0.0%	+33.8%	0.035%
8/3/2023	Barclays PLC	81,971	$0.92M	0.0%	+155.5%	0.141%
8/3/2023	Bank of New York Mellon Corp	150,247	$1.69M	0.0%	+18.4%	0.258%
7/25/2023	Raymond James & Associates	71,998	$0.81M	0.0%	-6.7%	0.123%
7/25/2023	DekaBank Deutsche Girozentrale	40,000	$0.42M	0.0%	+166.7%	0.069%
5/18/2023	International Biotechnology Trust PLC	433,751	$4.99M	1.4%	-32.3%	0.744%
5/16/2023	Hhlr Advisors LTD.	478,401	$5.51M	0.1%	-49.1%	0.820%
5/16/2023	Altium Capital Management LP	155,000	$1.79M	1.0%	N/A	0.266%
5/16/2023	Atlas Venture Life Science Advisors LLC	9,885,449	$113.88M	15.4%	+0.2%	16.955%
5/15/2023	Logos Global Management LP	1,700,000	$19.58M	2.8%	-20.9%	2.916%
5/12/2023	Martingale Asset Management L P	10,441	$0.12M	0.0%	-70.4%	0.018%
5/10/2023	B. Metzler seel. Sohn & Co. AG	18,973	$0.22M	0.0%	+22.1%	0.033%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	21,010	$0.24M	0.0%	N/A	0.036%
5/10/2023	Ovata Capital Management Ltd	15,000	$0.17M	0.1%	N/A	0.026%
5/9/2023	Integral Health Asset Management LLC	57,000	$0.66M	0.1%	N/A	0.098%
5/9/2023	Russell Investments Group Ltd.	23,626	$0.27M	0.0%	+32.1%	0.041%
5/8/2023	New York Life Investment Management LLC	42,369	$0.49M	0.0%	N/A	0.073%
5/8/2023	Federated Hermes Inc.	263,196	$3.03M	0.0%	+111,423.7%	0.451%
5/4/2023	Barclays PLC	32,088	$0.37M	0.0%	+32.4%	0.055%
5/3/2023	Jump Financial LLC	24,064	$0.28M	0.0%	-27.9%	0.041%
4/28/2023	SG Americas Securities LLC	11,183	$0.13M	0.0%	+14.1%	0.019%
4/24/2023	Inspire Investing LLC	39,722	$0.46M	0.1%	N/A	0.068%
4/18/2023	Assenagon Asset Management S.A.	578,851	$6.67M	0.0%	+120.1%	0.993%
4/14/2023	Raymond James & Associates	77,203	$0.89M	0.0%	+39.4%	0.132%
4/13/2023	Allspring Global Investments Holdings LLC	4,397	$51K	0.0%	N/A	0.008%

Data available starting January 2016

Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $24.73

$23.50

$25.08

50 Day Range

MA: $26.07

$22.41

$29.18

52 Week Range

Now: $24.73

$6.40

$30.27

Volume

616,906 shs

Average Volume

846,291 shs

Market Capitalization

$2.13 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Dyne Therapeutics?: Dyne Therapeutics' top insider shareholders include:
Jason P Rhodes (Director)
Venture Fund Xi LP Atlas (Major Shareholder)
Dirk Kersten (Director)
Joshua T Brumm (CEO)
Joshua T Brumm (Insider)
Susanna Gatti High (COO)
Oxana Beskrovnaya (Insider)
Wildon Farwell (Insider)
Jonathan Mcneill (Insider)
Richard William Scalzo (Insider)
Richard William Scalzo (SVP)
Learn More about top insider investors at Dyne Therapeutics.
Who are the major institutional investors of Dyne Therapeutics?: Dyne Therapeutics' top institutional investors include:
Vivo Capital LLC — 1.90%
Wasatch Advisors LP — 0.48%
Vida Ventures Advisors LLC — 0.47%
Raymond James & Associates — 0.20%
Arcadia Investment Management Corp MI — 0.04%
Allspring Global Investments Holdings LLC — 0.00%
Learn More about top institutional investors of Dyne Therapeutics stock.
Which institutional investors are selling Dyne Therapeutics stock?: During the last quarter, DYN stock was sold by these institutional investors:
Vida Ventures Advisors LLC
Wasatch Advisors LP
Allspring Global Investments Holdings LLC
Within the previous year, company insiders that have sold Dyne Therapeutics company stock include:
Jason P Rhodes (Director)
Venture Fund Xi LP Atlas (Major Shareholder)
Dirk Kersten (Director)
Joshua T Brumm (CEO)
Joshua T Brumm (Insider)
Susanna Gatti High (COO)
Oxana Beskrovnaya (Insider)
Wildon Farwell (Insider)
Jonathan Mcneill (Insider)
Richard William Scalzo (Insider)
Learn More investors selling Dyne Therapeutics stock.
Which institutional investors are buying Dyne Therapeutics stock?: During the last quarter, DYN stock was acquired by institutional investors including:
Vivo Capital LLC
Raymond James & Associates
Arcadia Investment Management Corp MI
Wetzel Investment Advisors Inc.
During the last year, these company insiders have bought Dyne Therapeutics stock:
Jason P Rhodes (Director)
Venture Fund Xi LP Atlas (Major Shareholder)
Learn More investors buying Dyne Therapeutics stock.